In addition, RUNX2 can interact with brahma-related gene 1 (BRG1)—a key regulator of CD44 and a major transcriptional regulator [24, 25]—to promote the invasion and migration processes via the regulation of CD44 in CRC cells. The gene discussed is CD44; the disease is colorectal carcinoma.